References
- Bartlett, V.L., Dhruva, S.S., Shah, N.D., Ryan, P., and Ross, J.S. (2019), “Feasibility of Using Real-world Data to Replicate Clinical Trial Evidence,” JAMA Network Open, 2, e1912869. DOI: 10.1001/jamanetworkopen.2019.12869.
- Franklin, J.M., Patorno, E., Desai, R.J., Glynn, R.J., Martin, D., Quinto, K., Pawar, A., Bessette, L.G., Lee, H., Garry, E.M., Gautam, N., and Schneeweiss, S. (2021), “Emulating Randomized Clinical Trials with Nonrandomized Real-world Evidence Studies: First Results from the RCT DUPLICATE Initiative,” Circulation, 143, 1002–1013. DOI: 10.1161/CIRCULATIONAHA.120.051718.
- Levenson, M., He, W., Chen, J., Fang, Y., Faries, D., Goldstein, B.A., Ho, M., Lee, K., Mishra-Kalyani, P., Rockhold, F., Wang, H., and Zink, R.C. (2021), “Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment,” Statistics in Biopharmaceutical Research, DOI: 10.1080/19466315.2021.1883473.